U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06916169) titled 'A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042' on April 02.

Brief Summary: The objective of this study is to evaluate the pharmacokinetic characteristics of AG2304 in healthy subjects.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Pharmacokinetics

Intervention: DRUG: AG2304

AG2304, Single-dose Oral Administration

DRUG: AG23041 and AG23042

AG23041/AG23042, Single-dose Oral Administration

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd

Published by HT Digital Content Services with permission from Health...